Mirum CEO Christopher Peetz sells 30,000 shares for $2.95 million
Reuters2026/09/03 22:53- Mirum Pharmaceuticals CEO Christopher Peetz sold 30,000 common shares on Sep. 1, 2026 at weighted average prices of USD 98.08 and USD 98.91.
- Disposition followed the exercise of 30,000 employee stock options at USD 2.94 per share.
- Direct holdings ended at 194,440 shares.
- Indirect holdings via the Peetz Family Trust totaled 187,500 shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The first major "exam" after the Cook era! Morgan Stanley: Apple's (AAPL.US) autumn launch event is the most important in ten years; the first foldable iPhone may spark a new wave of growth
Morgan Stanley analysts stated that Apple's upcoming "Surprise and Shine" autumn product launch event on September 9 may become the company's most important product release in nearly a decade.
10-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - Germany vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
